LACOSAMIDE
NDC 70710-1886, Lacosamide, injection, from Zydus Pharmaceuticals USA Inc..
- Product NDC
- 70710-1886
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209465
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1886 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACOSAMIDE10 mg/mL
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70710-1886-6 | 70710188606 | 10 VIAL in 1 CARTON (70710-1886-6) / 20 mL in 1 VIAL (70710-1886-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/16a9afd2-35a6-44a9-b1d9-ca195c8640d7
Use it
Look up 70710-1886 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1886 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70710-1886. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.